Viewing Study NCT01569295

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2026-01-11 @ 10:28 AM
Study NCT ID: NCT01569295
Status: COMPLETED
Last Update Posted: 2020-03-10
First Post: 2012-03-27
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Zydelig View
None CLL View
None CAL-101 View
None GS 1101 View
None GS-1101 View
None PI3K View
None Rituxan View
None Rituximab View
None Bendamustine View
None Leukemia View
None idelalisib View